Role of insulin-like growth factor-1R system in colorectal carcinogenesisDONOVAN, Erin A; KUMMAR, Shivaani.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 91-98, issn 1040-8428, 8 p.Article

Non-small-cell lung cancer vaccine therapy : A concise reviewO'MAHONY, Deirdre; KUMMAR, Shivaani; GUTIERREZ, Martin E et al.Journal of clinical oncology. 2005, Vol 23, Num 35, pp 9022-9028, issn 0732-183X, 7 p.Article

Targeting epigenetic abnormalities with histone deacetylase inhibitorsCONLEY, Barbara A; WRIGHT, John J; KUMMAR, Shivaani et al.Cancer. 2006, Vol 107, Num 4, pp 832-840, issn 0008-543X, 9 p.Article

Drug development in oncology : classical cytotoxics and molecularly targeted agentsKUMMAR, Shivaani; GUTIERREZ, Martin; DOROSHOW, James H et al.British journal of clinical pharmacology. 2006, Vol 62, Num 1, pp 15-26, issn 0306-5251, 12 p.Article

Primary non-Hodgkin's lymphoma of the liverNORONHA, Vanita; SHAFI, Nelofar Q; OBANDO, J. Antonio et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 199-207, issn 1040-8428, 9 p.Article

Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detectionXIAOHONG CHEN; GARDNER, Erin R; GUTIERREZ, Martin et al.Journal of chromatography. B. 2007, Vol 858, Num 1-2, pp 302-306, issn 1570-0232, 5 p.Article

Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography-electrospray mass spectrometryHWANG, Kyunghwa; SCRIPTURE, Charity D; GUTIERREZ, Martin et al.Journal of chromatography. B. 2006, Vol 830, Num 1, pp 35-40, issn 1570-0232, 6 p.Article

Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignanciesKUMMAR, Shivaani; GUTIERREZ, Martin E; HORNEFFER, Yvonne R et al.European journal of cancer (1990). 2010, Vol 46, Num 2, pp 340-347, issn 0959-8049, 8 p.Article

Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignanciesKUMMAR, Shivaani; GUTIERREZ, Martin; MELILLO, Giovanni et al.Clinical cancer research. 2007, Vol 13, Num 18, pp 5411-5417, issn 1078-0432, 7 p., 1Article

A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and LymphomasRAJAN, Arun; KELLY, Ronan J; MANNARGUDI, Baskar et al.Clinical cancer research (Print). 2011, Vol 17, Num 21, pp 6831-6839, issn 1078-0432, 9 p.Article

Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasKUMMAR, Shivaani; GUTIERREZ, Martin E; TREPEL, Jane et al.European journal of cancer (1990). 2011, Vol 47, Num 7, pp 997-1005, issn 0959-8049, 9 p.Article

Population pharmacokinetic analysis of sorafenib in patients with solid tumoursJAIN, Lokesh; WOO, Sukyung; FIGG, William D et al.British journal of clinical pharmacology. 2011, Vol 72, Num 2, pp 294-305, issn 0306-5251, 12 p.Article

A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomasKUMMAR, Shivaani; GUTIERREZ, Martin E; GARDNER, Erin R et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 2, pp 383-389, issn 0344-5704, 7 p.Article

Monitoring Drug-Induced yH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor CellsWANG, Lihua H; PFISTER, Thomas D; KINDERS, Robert J et al.Clinical cancer research (Print). 2010, Vol 16, Num 3, pp 1073-1084, issn 1078-0432, 12 p.Article

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumorsWOONDONG JEONG; SOOK RYUN PARK; DOROSHOW, James H et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 340-346, issn 0167-6997, 7 p.Article

Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomasKUMMAR, Shivaani; GUTIERREZ, Martin E; ANDERSON, Lawrence W et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 4, pp 917-923, issn 0344-5704, 7 p.Article

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid TumorsRAJAN, Arun; CARTER, Corey A; SPENCER, Shawn et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2344-2351, issn 1078-0432, 8 p.Article

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced MalignanciesKUMMAR, Shivaani; KINDERS, Robert; MURGO, Anthony J et al.Journal of clinical oncology. 2009, Vol 27, Num 16, pp 2705-2711, issn 0732-183X, 7 p.Article

Designing Phase 0 Cancer Clinical Trials : FOCUSON Phase O Clinical trialsMURGO, Anthony J; KUMMAR, Shivaani; HOLLINGSHEAD, Melinda et al.Clinical cancer research. 2008, Vol 14, Num 12, pp 3675-3682, issn 1078-0432, 8 p.Article

Pharmacodynamic Assessment of Histone Deacetylase Inhibitors : Infrared Vibrational Spectroscopic Imaging of Protein AcetylationTSOCHING CHEN; LEE, Min-Jung; YEONG SANG KIM et al.Analytical chemistry (Washington, DC). 2008, Vol 80, Num 16, pp 6390-6396, issn 0003-2700, 7 p.Article

Cediranib for Metastatic Alveolar Soft Part SarcomaKUMMAR, Shivaani; ALLEN, Deborah; SIMON, Richard et al.Journal of clinical oncology. 2013, Vol 31, Num 18, pp 2296-2302, issn 0732-183X, 7 p.Article

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and LymphomasKUMMAR, Shivaani; JIUPINGJI; NEWMAN, Edward M et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1726-1734, issn 1078-0432, 9 p.Article

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and HyperbilirubinemiaPEER, Cody J; SISSUNG, Tristan M; FEDERSPIEL, Joel et al.Clinical cancer research (Print). 2012, Vol 18, Num 7, pp 2099-2107, issn 1078-0432, 9 p.Article

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck CancerARGIRIS, Athanassios; DUFFY, Austin G; ZHONG CHEN et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5755-5764, issn 1078-0432, 10 p.Article

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non-Small-Cell Lung Cancer Receiving SorafenibKELLY, Ronan J; RAJAN, Arun; LIQIANG XI et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1190-1199, issn 1078-0432, 10 p.Article